Proteomic biomarkers for psychiatric disorders: a progress update.

about

The Utility of Multiplex Assays for Identification of Proteomic Signatures in Psychiatry.

P2860

Q38869523-CD081D3D-F925-4238-BD8A-33793C3FF7F3

P2860

Proteomic biomarkers for psychiatric disorders: a progress update.

Item

http://www.wikidata.org/entity/Q50763945

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Proteomic biomarkers for psychiatric disorders: a progress update.

@en

Proteomic biomarkers for psychiatric disorders: a progress update.

@nl

type

Item

label

Proteomic biomarkers for psychiatric disorders: a progress update.

@en

Proteomic biomarkers for psychiatric disorders: a progress update.

@nl

prefLabel

Proteomic biomarkers for psychiatric disorders: a progress update.

@en

Proteomic biomarkers for psychiatric disorders: a progress update.

@nl

P1476

Proteomic biomarkers for psychiatric disorders: a progress update.

@en

P2093

Christoph W Turck

http://www.w3.org/2001/XMLSchema#string

P2860

Modelling schizophrenia using human induced pluripotent stem cells.

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.

The positives, protocols, and perils of genome-wide association.

Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia.

The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics.

Proteomic technologies for biomarker studies in psychiatry: advances and needs.

Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia.

P304

189-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/BMM.12.6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Martins-de-Souza

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221981233

http://www.w3.org/2001/XMLSchema#string

P698

22448792

http://www.w3.org/2001/XMLSchema#string

Proteomic biomarkers for psychiatric disorders: a progress update.

about

P2860

P2860

Proteomic biomarkers for psychiatric disorders: a progress update.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698